We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$626M
AUM Growth
+$8.63M
Cap. Flow
+$2.02M
Cap. Flow %
0.32%
Top 10 Hldgs %
27.63%
Holding
316
New
18
Increased
76
Reduced
109
Closed
13

Top Buys

Rank Stock Value
1
UA icon
Under Armour Class C
UA
+$4.22M
2
SBAC icon
SBA Communications
SBAC
+$780K
3
APA icon
APA Corp
APA
+$729K
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$711K
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$529K

Top Sells

Rank Stock Value
1
UAA icon
Under Armour
UAA
+$4.6M
2
SNDK
SANDISK CORP
SNDK
+$1.38M
3
HUSI.PRG
HSBC USA INC DEP SHS REPSTG 1/40 PRD SER G
HUSI.PRG
+$794K
4
GS icon
Goldman Sachs
GS
+$590K
5
CLVS
Clovis Oncology, Inc.
CLVS
+$414K

Sector Composition

Rank Sector Weight
1 Healthcare 23.93%
2 Industrials 14.1%
3 Consumer Staples 12.44%
4 Technology 8.21%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMP
26
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.38M 1.02%
83,961
-850
-1% -$60.3K
BAC icon
27
Bank of America
BAC
$435B
$6.14M 0.98%
462,804
+4,806
+1% +$67.5K
MSFT icon
28
Microsoft
MSFT
$2.84T
$6.1M 0.97%
119,195
+660
+0.6% +$34.3K
C icon
29
Citigroup
C
$222B
$5.37M 0.86%
126,795
-210
-0.2% -$9.29K
SPG icon
30
Simon Property Group
SPG
$74.5B
$5.22M 0.83%
24,051
-100
-0.4% -$20.4K
ACAD icon
31
Acadia Pharmaceuticals
ACAD
$4.25B
$5.18M 0.83%
159,590
+4,400
+3% +$147K
TMO icon
32
Thermo Fisher Scientific
TMO
$211B
$5.07M 0.81%
34,312
-500
-1% -$73.8K
GILD icon
33
Gilead Sciences
GILD
$161B
$5.04M 0.8%
60,365
+450
+0.8% +$39.9K
BA icon
34
Boeing
BA
$165B
$5M 0.8%
38,499
-175
-0.5% -$22.8K
EPD icon
35
Enterprise Products Partners
EPD
$83.8B
$4.98M 0.8%
170,170
+1,007
+0.6% +$27K
CSCO icon
36
Cisco
CSCO
$450B
$4.92M 0.79%
171,385
-700
-0.4% -$19.6K
T icon
37
AT&T
T
$165B
$4.87M 0.78%
149,151
+156
+0.1% +$4.64K
UAA icon
38
Under Armour
UAA
$3B
$4.75M 0.76%
118,485
-115,724
-49% -$4.6M
MRK icon
39
Merck
MRK
$324B
$4.61M 0.74%
83,761
+241
+0.3% +$12.8K
RTX icon
40
RTX Corp
RTX
$287B
$4.51M 0.72%
69,881
+6,022
+9% +$385K
IBM icon
41
IBM
IBM
$202B
$4.35M 0.69%
29,951
-79
-0.3% -$11.3K
MO icon
42
Altria Group
MO
$122B
$4.34M 0.69%
62,947
– –
CVX icon
43
Chevron
CVX
$388B
$4.2M 0.67%
40,020
+2,083
+5% +$210K
UA icon
44
Under Armour Class C
UA
$2.92B
$4.17M 0.67%
+114,470
New +$4.22M
EL icon
45
Estee Lauder
EL
$29B
$4.12M 0.66%
45,234
– –
EOG icon
46
EOG Resources
EOG
$78B
$3.93M 0.63%
47,105
+140
+0.3% +$11.2K
CVS icon
47
CVS Health
CVS
$137B
$3.92M 0.63%
40,961
+2,437
+6% +$243K
QQQ icon
48
Invesco QQQ Trust
QQQ
$455B
$3.53M 0.56%
32,845
+1,116
+4% +$121K
KSU
49
DELISTED
Kansas City Southern
KSU
$3.36M 0.54%
37,280
-250
-0.7% -$22.8K
VRTX icon
50
Vertex Pharmaceuticals
VRTX
$121B
$3.35M 0.54%
38,970
– –
1
2
3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Gerald L. Ray & Associates held 316 positions worth $626M, up 1.4% from $617M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gerald L. Ray & Associates's Q2 2016 filing shows 18 new, 76 increased, 109 reduced and 13 closed positions. Its largest new stake was Under Armour Class C: 114,470 shares worth $4.17M. The largest sale was Under Armour, an estimated $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q2 2016 buy was Under Armour Class C: 114,470 shares worth $4.17M.
  • Gerald L. Ray & Associates added most to APA Corp in Q2 2016, an estimated $729K increase.
  • Gerald L. Ray & Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $4.6M.
  • Gerald L. Ray & Associates fully exited SANDISK CORP in Q2 2016, selling an estimated $1.38M.
  • Gerald L. Ray & Associates's ten largest holdings make up 28% of its $626M portfolio in Q2 2016.
  • Gerald L. Ray & Associates opened 18 new positions and closed 13 in Q2 2016.
  • Gerald L. Ray & Associates's portfolio value rose 1.4% quarter-over-quarter to $626M.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.